EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Efficacy and safety of Kegan Liyan oral liquid for patients with acute pharyngitis: A randomized, double-blinded, placebo-controlled, multi-center trial

Luoqi Lin, Jingmin Xiao, Lei Wu, Feiting Fan, Wenjie Feng, Jun Wei, Guangen Wang, Gang Liu, Wei Zhang, Yun Lu, Yunhui Li, Lijun Lu und 18 weitere

Phytomedicine · 2024-11 · 134 · 155960

DOI: 10.1016/j.phymed.2024.155960 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Phytomedicine, 2024-11. Verfasst von Luoqi Lin und 29 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome/The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, PR …. Hauptthemen laut MEDLINE: Pharyngitis, Drugs, Chinese Herbal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Alleviating the sore throat caused by acute pharyngitis is a primary patient concern. However, antibiotics are not commonly recommended drugs, and abuse can lead to serious consequences such as drug resistance. Therefore, seeking alternative treatments is necessary. PURPOSE: To investigate the efficacy and safety of Kegan Liyan (KGLY) oral liquid for patients with acute pharyngitis. STUDY DESIGN: Randomized, double-blinded, placebo-controlled, multi-center study. METHODS: Participants from 17 hospitals were randomly assigned 1:1 to receive KGLY oral liquid or placebo for five days. Assessments occurred at baseline, day 3, and day 6. The primary outcome was the recovery rate. Secondary outcomes included sore throat and cough visual analogue scale (VAS), the area under the curve (AUC) of sore throat VAS, time to sore throat relief and recovery, proportion of participants with sore throat relief and recovery, traditional Chinese medicine (TCM) syndrome score, single TCM manifestation score and use of acetaminophen. RESULTS: Involving 239 participants (120 in KGLY and 119 in placebo group), the study found a significantly higher recovery rate on day 6 in the KGLY group (between-group difference, 27.20 % [15.00 % to 39.40 %], p < 0.001). On day 3 and 6, the KGLY group showed significantly larger reductions in sore throat (-3.02 vs -2.37, p = 0.001; -4.66 vs -3.64, p < 0.001) and cough VAS scores (-1.55 vs -1.05, p = 0.004; -2.28 vs -1.56, p < 0.001) from baseline. KGLY oral liquid lowered the AUC of sore throat VAS score (-2.33 [-4.10 to -0.56], p = 0.011), shortened time to sore throat recovery (hazard ratio, 0.42 [0.30 to 0.59], p < 0.001), increased sore throat recovery rate at day 6 (75.00 % vs 42.86 %, p < 0.001), decreased the TCM syndrome score (-2.03 [-2.69 to -1.37], p < 0.001), and improved individual TCM symptoms compared to placebo. No significant differences between the groups in acetaminophen usage. KGLY oral liquid was safe and tolerated. CONCLUSION: KGLY oral liquid may be a beneficial and safe alternative treatment for acute pharyngitis, which can alleviate symptoms such as sore throat, swollen throat, cough, and phlegm production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharyngitisDrugs, Chinese HerbalHumansDouble-Blind MethodMaleFemaleAdultAcute DiseaseYoung AdultAdministration, OralMiddle AgedMedicine, Chinese TraditionalTreatment OutcomeCough

Stichwörter der Autor:innen

Acute pharyngitisChinese patent medicineKegan Liyan oral liquidRandomized controlled trialSore throat

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • State Key Laboratory of Traditional Chinese Medicine Syndrome/The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, PR China; State Key Laboratory of Dampness Syndrome of Chinese Medicine,…
  • State Key Laboratory of Traditional Chinese Medicine Syndrome/The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, PR China; Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, P…
  • Qinhuangdao Hospital of Traditional Chinese Medicine, Hebei, PR China.
  • Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Hubei, PR China.
  • Handan Hospital of Traditional Chinese Medicine, Hebei, PR China.
  • The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Anhui, PR China.

Zitieren

APA

Lin, L., Xiao, J., Wu, L., Fan, F., Feng, W., Wei, J., Wang, G., Liu, G., Zhang, W., Lu, Y., Li, Y., Lu, L., Li, H., Sun, S., Gou, J., Dang, Y., Sun, X., Jiang, B., Qin, J., …, & Lin, L. (2024). Efficacy and safety of Kegan Liyan oral liquid for patients with acute pharyngitis: A randomized, double-blinded, placebo-controlled, multi-center trial. Phytomedicine, 134, 155960. https://doi.org/10.1016/j.phymed.2024.155960

Vancouver

Lin L, Xiao J, Wu L, Fan F, Feng W, Wei J, et al. Efficacy and safety of Kegan Liyan oral liquid for patients with acute pharyngitis: A randomized, double-blinded, placebo-controlled, multi-center trial. Phytomedicine. 2024;134:155960. doi:10.1016/j.phymed.2024.155960

BibTeX
@article{Lin2024,
  author = {Lin, Luoqi and Xiao, Jingmin and Wu, Lei and Fan, Feiting and Feng, Wenjie and Wei, Jun and Wang, Guangen and Liu, Gang and Zhang, Wei and Lu, Yun and Li, Yunhui and Lu, Lijun and Li, Huimin and Sun, Shengde and Gou, Jian and Dang, Yuqi and Sun, Xuwu and Jiang, Baihua and Qin, Jiangbo and Zhen, Hui and Fang, Yun and Ding, Junping and Huang, Minling and Zhao, Wenhan and Cai, Yan and Huang, Kaifeng and Tong, Xiaoping and Chen, Yuanbin and Zhang, Hongchun and Lin, Lin},
  title = {Efficacy and safety of Kegan Liyan oral liquid for patients with acute pharyngitis: A randomized, double-blinded, placebo-controlled, multi-center trial},
  journal = {Phytomedicine},
  year = {2024},
  volume = {134},
  pages = {155960},
  doi = {10.1016/j.phymed.2024.155960}
}
Kostenlos starten →